Biochemical analysis results
Table 1 shows the mean±standard deviation (SD) values of the RFTN-1 and 8-iso-PGF2α results obtained after the model applied in the Sham, control, I/R and treatment groups and the distribution of the lower and upper values according to the groups.
Considering the RFTN-1 and 8-iso-PGF2α values; It was observed that the values of the sham, I/R and treatment 2 groups statistically significantly increased as compared to the control group (p<0.05). The RFTN-1 value of the I/R group was found to be significantly increased compared to the sham group (p<0.05). Although an increase in 8-iso-PGF2α value was observed in the I/R group compared to the sham group, no significant difference was found (p>0,005). It was observed that the RFTN-1 and 8-iso-PGF2α values of the treatment 1 and combined treatment groups were significantly decreased compared to the sham group (p<0.05). It was observed that the RFTN-1 and 8-iso-PGF2α values of the treatment 2 group decreased compared to the sham group, but only the 8-iso-PGF2α values varied statistically (p<0.05). RFTN-1 and 8-iso-PGF2α values of the tratment 1, treatment 2 and combined treatment groups were found to be significantly decreased compared to the I/R group (p<0.05). 8-iso-PGF2α value of the treatment 1 group was statistically decreased compared to the treatment 2 group (p<0.05). It was found that both RFTN-1 and 8-iso-PGF2α values of the combined treatment group were statistically significantly decreased compared to the treatment 2 group (p<0.05).
Histopathological results
Conjoined dilated structures, pericapillary and inflammatory cells were seen in the Sham and I/R groups. In addition, edema formation and fibrinoid necrosis were observed in the I/R group. Few pericapillaries and mild inflammation was seen in treatment 2 group. Decreased pericapillary and inflammatory cells, mild dilatation of vascular structure were observed treatment 1 group. Significant improvement was seen in the combined treatment (B17+RSV) group (Fig 1). It was observed that there was no edema, hemorrhage and infection in the combined treatment group (Table 2).
The results obtained from our study showed that the combined treatment of RSV and B17 may be effective in reducing both bichemical and histopathological damage due to bladder I/R injury. One of the most important target structures of free radicals formed as a result of I/R is lipids. Lipid peroxidation is considered by some researchers to be the key to I/R injury
(Sahna et al., 2006). 8-iso-PGF2α, a product of lipid peroxidation, are usually checked. 8-iso-PGF2α is chemically more stable than other isoprostanes and studies were shown that it was a reliable marker that could be measured as an indicator of oxidative stress in plasma and tissue samples
(Bratslavsky et al., 2003).
In our study, 8-iso-PGF2α value was lower in the treatment 1 and treatment 2 groups compared to the I/R group (p<0.05). In addition, the most decrease in 8-iso-PGF2α value was observed in the combined treatment (RSV+B17) group (p<0.05). The antioxidant role of RSV is to compete with coenzyme Q, capture O2-(Superoxide radical) and inhibit lipid peroxidation
(Avnioglu et al., 2022). In our study, the low levels of 8-iso-PGF2α in the treatment group may suggest that RSV inhibits lipid peroxidation as a strong antioxidant
in vivo. The high level of 8-iso-PGF2α value in the I/R group indicates that tissue damage occurs due to lipid peroxidation and leukocyte activation after I/R injury. In addition, the 30-minute ischemia and reperfusion time we applied in our study suggests that it may be effective in the high level of 8-iso-PGF2α. In our study, the highest increase in 8-iso-PGF2α value occurred at the 30th minute of reperfusion. Similar evaluations regarding this period are recorded in the literature
(Guler et al., 2004; Lin et al., 2000).
Another parameter used in this study was RFTN-1.
Saeki et al (2003) reported that RFTN-1 modulates lipid rafts and has some enzymatic activities related to lipid metabolism. RFTN-1 is a biochemical parameter used to diagnose inflammatory diseases and characterize the immune response. In this present study, RFTN-1 levels were found to be high in the I/R and sham groups, while RFTN-1 levels were found to be lower in the therapeutic groups (treatment 1 and 2). But, it was observed that RFTN-1 levels decreased significantly, especially in the treatment 1 group (p<0.05). This is the first study to investigate the protective effect of RSV and B17 on RFTN-1 against bladder I/R injuries. This situation contributes to the originality of our study. However, in literature, there were studies evaluating different vitamins in I/R models
(Jing et al., 2013; Jarrod, 2000).
Although the dose of RSV varies between 10(-6) mg/kg and 20 mg/kg in the literature, there are studies in which different doses are applied
(Gedik et al., 2008). In our study, we used resveratrol at a dose of 50 mg/kg and showed that resveratrol at this dose significantly reduced tissue damage (Table 1).
In our study, it was observed that RSV and B17 showed similar protective effects histopathologically. The histopathologically mild inflammation and the presence of a small number of pericapillaries in the B17 applied groups indicate that it is effective in tissue repair. Pericapillary and inflammatory cells decreased in treatment 1 group. Histopathologically significant improvement occurred in the combined therapy (RSV+B17) group.
As a result, bladder I/R injury and ROS formation occur due to changes in the blood flow of the bladder during filling and emptying of the bladder. In this study, we showed with biochemical data that RSV and B17 can play an active role in injuries related to bladder I/R. In addition, our research, supported by histopathological data, has clinically demonstrated that RSV and B17 have a healing effect in injuries related to bladder I/R.